294 views
Photo from Envato Elements

CCCS OKs Hanwha’s proposed acquisition of Dyna-Mac

CCCS conducted a public consultation from 4 to 18 October.

The Competition and Consumer Commission of Singapore (CCCS) has cleared Hanwha’s proposed acquisition of Dyna-Mac for $0.67 per share.

From 4 to 18 October, CCCS sought public feedback from various stakeholders, including competitors and customers of Hanwha and Dyna-Mac. 

The competition watchdog concluded that the proposed acquisition will not infringe the section 54 prohibition of the Competition Act 2004, which prohibits mergers that may substantially lessen competition within any market in Singapore.

CCCS found that the transaction is unlikely to lead to a substantial lessening of competition in the supply of offshore plants because:

  • Dyna-Mac’s market share in the global supply of topside modules is unlikely to be high.
  • Customers continue to have sufficient choice of suppliers for topside modules on a global basis.
  • Dyna-Mac’s topside modules represent only a small portion of those used in the global supply of offshore plants.
Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.